Balaxi Pharmaceuticals consolidated net profit rises 472.60% in the March 2021 quarter

Sales rise 352.18% to Rs 52.95 crore

Net profit of Balaxi Pharmaceuticals rose 472.60% to Rs 8.36 crore in the quarter ended March 2021 as against Rs 1.46 crore during the previous quarter ended March 2020. Sales rose 352.18% to Rs 52.95 crore in the quarter ended March 2021 as against Rs 11.71 crore during the previous quarter ended March 2020.

For the full year,net profit rose 525.25% to Rs 38.14 crore in the year ended March 2021 as against Rs 6.10 crore during the previous year ended March 2020. Sales rose 406.97% to Rs 231.33 crore in the year ended March 2021 as against Rs 45.63 crore during the previous year ended March 2020.

 

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales52.9511.71 352 231.3345.63 407 OPM %19.4715.46 -18.3317.97 - PBDT10.032.41 316 44.638.79 408 PBT9.972.40 315 44.338.78 405 NP8.361.46 473 38.146.10 525

Powered by Capital Market - Live News